Hikal unveils High Potency API Lab at integrated Innovation Centre in Pune

Hikal Ltd., which caters to planetary beingness sciences companies, has announced the inauguration of its High Potency Active Pharmaceutical Ingredient (HPAPI) Laboratory astatine its Integrated Innovation Centre successful Pune.

This installation volition further fortify its end-to-end CDMO capabilities and heighten its quality to safely make and test, and present ‘highly potent compounds’ for the planetary pharmaceutical industry, it said. 

The caller cGMP-compliant HPAPI Laboratory is equipped with isolators designed to conscionable Occupational Exposure Band 5 (OEB-5) requirements. 

The laboratory is purpose-built to enactment the improvement of analyzable oncology and speciality molecules, including components of Antibody Drug Conjugates (ADCs), Peptide Drug Conjugates (PDCs), and Proteolysis Targeting Chimeras (PROTACs), the institution said.

“Our caller HPAPI laboratory represents a captious measurement guardant successful expanding our capabilities and reinforcing our unwavering committedness to innovation, information and lawsuit excellence,” said Sameer Hiremath, Vice Chairman & Managing Director, Hikal Ltd.

“With this caller summation to our exertion toolbox, we are well-positioned to conscionable the increasing request for potent molecule improvement portion maintaining the highest planetary standards of containment and compliance,” helium added.